ResMed (NYSE:RMD) Given New $195 00 Price Target at Mizuho themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
ResMed (NYSE:RMD – Free Report) had its price target hoisted by Royal Bank of Canada from $181.00 to $182.00 in a research note released on Thursday, Benzinga reports. The brokerage currently has a sector perform rating on the medical equipment provider’s stock. A number of other brokerages also recently weighed in on RMD. StockNews.com assumed […]
Ieq Capital LLC grew its stake in ResMed Inc. (NYSE:RMD – Free Report) by 118.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,106 shares of the medical equipment provider’s stock after acquiring an additional 3,314 shares during the quarter. Ieq Capital LLC’s […]
5 things to watch on the ASX 200 on Monday fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
Nomura Asset Management Co. Ltd. lowered its position in ResMed Inc. (NYSE:RMD – Free Report) by 1.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,845 shares of the medical equipment provider’s stock after selling 712 shares during the period. Nomura Asset Management Co. Ltd.’s […]